Evidence-based recommendations of postoperative radiotherapy in lung cancer from Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Clin. transl. oncol. (Print)
; 18(4): 331-341, abr. 2016. tab
Article
in English
| IBECS
| ID: ibc-150446
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Locally advanced non-small cell lung cancer (NSCLC) is a diversified illness in which postoperative radiation therapy (PORT) for complete resection with positive hiliar (pN1) and/or mediastinal (pN2) lymph nodes is controversial. Although several studies have shown that PORT has beneficial effects, randomized trials are needed to demonstrate its impact on overall survival. In this review, the Spanish Radiation Oncology Group for Lung Cancer describes the most relevant literature on PORT in NSCLC patients stage pN1-2. In addition, we have outlined the current recommendations of different national and international clinical guidelines and have also specified practical issues regarding treatment volume definition, doses and fractionation (AU)
RESUMEN
No disponible
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Evidence-Based Practice
/
Lung Neoplasms
Type of study:
Controlled clinical trial
/
Practice guideline
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2016
Document type:
Article
Institution/Affiliation country:
Hospital Clínic Barcelona/Spain
/
Hospital Universitario Quirón Madrid/Spain
/
Hospital Universitario Ramón y Cajal/Spain
/
Hospital Universitario Santiago de Compostela/Spain
/
Instituto Oncológico Cartuja/Spain
/
Parc de Salut Mar/Spain